Rational therapy of pelvic inflammatory disease
Features of the etiology and pathogenesis of the pelvic inflammatory diseases (PID) determine the dire need for antibiotic therapy, while avoiding polypharmacy in order to improve compliance, particularly in the prescription of the empirical treatment of uncomplicated PID. The article presents data...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
IP Berlin A.V.,
2014-02-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_8c0a330b46df4c47aefb9d0801f05664 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a A L Tikhomirov |e author |
| 245 | 0 | 0 | |a Rational therapy of pelvic inflammatory disease |
| 260 | |b IP Berlin A.V., |c 2014-02-01T00:00:00Z. | ||
| 500 | |a 2079-5696 | ||
| 500 | |a 2079-5831 | ||
| 520 | |a Features of the etiology and pathogenesis of the pelvic inflammatory diseases (PID) determine the dire need for antibiotic therapy, while avoiding polypharmacy in order to improve compliance, particularly in the prescription of the empirical treatment of uncomplicated PID. The article presents data on the effectiveness of a new generation fluoroquinolone - drug Avelox® (moxifloxacin) in monotherapy genital mixed infection. | ||
| 546 | |a RU | ||
| 690 | |a pelvic inflammatory diseases | ||
| 690 | |a fluoroquinolones | ||
| 690 | |a moxifloxacin | ||
| 690 | |a polypharmacy | ||
| 690 | |a patient compliance | ||
| 690 | |a Gynecology and obstetrics | ||
| 690 | |a RG1-991 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Гинекология, Vol 16, Iss 1, Pp 115-118 (2014) | |
| 787 | 0 | |n https://gynecology.orscience.ru/2079-5831/article/viewFile/28345/pdf | |
| 787 | 0 | |n https://doaj.org/toc/2079-5696 | |
| 787 | 0 | |n https://doaj.org/toc/2079-5831 | |
| 856 | 4 | 1 | |u https://doaj.org/article/8c0a330b46df4c47aefb9d0801f05664 |z Connect to this object online. |